Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

NLR

  • You have access
    Early Serum and Hematological Responses to Pembrolizumab Therapy as Predictors of Survival in Metastatic Urothelial Cancer
    MOTOHIRO FUJIWARA, RYO FUJIWARA, TETSUYA URASAKI, TOMOHIKO OGUCHI, YOSHINOBU KOMAI, NOBORU NUMAO, SHINYA YAMAMOTO, JUNJI YONESE and TAKESHI YUASA
    Anticancer Research April 2022, 42 (4) 2045-2051; DOI: https://doi.org/10.21873/anticanres.15685
  • You have access
    Laboratory Parameters Associated With Inflammation Do Not Affect PD-L1 Expression in Non-small Cell Lung Cancer
    MARTIN SVATON, MARIE DROSSLEROVA, ONDREJ FISCHER, MILOSLAV MAREL, MICHAL HRNCIARIK, ONDREJ VENCLICEK, PETR ZUNA, MICHAL SVOBODA, JIRI BLAZEK, MONIKA BRATOVA, ANDREA MULLEROVA, BOHUSLAVA VANKOVA and DANIEL KREJCI
    Anticancer Research March 2022, 42 (3) 1563-1569; DOI: https://doi.org/10.21873/anticanres.15630
  • You have access
    Neutrophil-to-lymphocyte Ratio as a Prognostic Factor for Colon Cancer in Elderly Patients: A Propensity Score Analysis
    JUNICHI MAZAKI, KENJI KATSUMATA, HIROKI SUJINO, RYUTARO UDO, TOMOYA TAGO, KENTA KASAHARA, HIROSHI KUWABARA, MASANOBU ENOMOTO, TETSUO ISHIZAKI, YUICHI NAGAKAWA and AKIHIKO TSUCHIDA
    Anticancer Research September 2021, 41 (9) 4471-4478; DOI: https://doi.org/10.21873/anticanres.15256
  • You have access
    Pre-treatment Neutrophil-to-Lymphocyte Ratio Predicts Efficacy of Eribulin for Soft-tissue Sarcoma
    YASUYOSHI SATO, KENJI NAKANO, NAOKI FUKUDA, XIAOFEI WANG, TETSUYA URASAKI, AKIHIRO OHMOTO, MAYU YUNOKAWA, MAKIKO ONO, JUNICHI TOMOMATSU, KEIKO HAYAKAWA, YUKI FUNAUCHI, TAISUKE TANIZAWA, KEISUKE AE, SEIICHI MATSUMOTO and SHUNJI TAKAHASHI
    Anticancer Research January 2021, 41 (1) 527-532; DOI: https://doi.org/10.21873/anticanres.14804
  • You have access
    Neutrophil–to–Lymphocyte Ratio as a Prognostic Indicator in Patients With Unresectable Gastric Cancer
    YUKI MURAKAMI, HIROAKI SAITO, SHOTA SHIMIZU, YUSUKE KONO, YUJI SHISHIDO, KOZO MIYATANI, TOMOYUKI MATSUNAGA, YOJI FUKUMOTO and YOSHIYUKI FUJIWARA
    Anticancer Research May 2019, 39 (5) 2583-2589; DOI: https://doi.org/10.21873/anticanres.13381
  • You have access
    Clinical Characteristics of Liver Metastasis in Nivolumab-treated Patients with Non-small Cell Lung Cancer
    TAKAYUKI SHIROYAMA, HIDEKAZU SUZUKI, MOTOHIRO TAMIYA, AKIHIRO TAMIYA, AYAKO TANAKA, NORIO OKAMOTO, KENJI NAKAHAMA, YOSHIHIKO TANIGUCHI, SHUN-ICHI ISA, TAKAKO INOUE, FUMIO IMAMURA, SHINJI ATAGI and TOMONORI HIRASHIMA
    Anticancer Research August 2018, 38 (8) 4723-4729; DOI: https://doi.org/10.21873/anticanres.12779
  • You have access
    Living Donor Liver Transplantation for Hepatocellular Carcinoma within Milan Criteria in the Present Era
    TOMOHARU YOSHIZUMI, NORIFUMI HARIMOTO, SHINJI ITOH, HIROHISA OKABE, KOICHI KIMURA, HIDEAKI UCHIYAMA, TORU IKEGAMI, TETSUO IKEDA and YOSHIHIKO MAEHARA
    Anticancer Research January 2016, 36 (1) 439-445;
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire